Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICE-AF: Semaglutide Prior to Catheter Ablation in Atrial Fibrillation
NCT07389941Phase 4Not yet recruiting
- Sponsor
- University of Lübeck
- Start
- Oct 2026
- Primary completion
- Apr 2029
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of semaglutide in Atrial fibrillation (AFib), sponsored by University of Lübeck. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07389941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07389941.